Overview of Human Biomonitoring

Human brucellosis: An overview

Human Biomonitoring in Switzerland

In her Postulate of 20 March 2008, National Councillor Moser (Green Liberal, Canton Zurich) requested the Federal Council to consider the introduction of systematic analysis of various groups of chemicals (pesticides, PCBs, UV filters, etc.) to which the Swiss population is exposed. In its response of 6 June 2008, the Federal Council stated that it was prepared to investigate how existing resea...

Human biomonitoring: state of the art.

Human biomonitoring (HBM) of dose and biochemical effect nowadays has tremendous utility providing an efficient and cost effective means of measuring human exposure to chemical substances. HBM considers all routes of uptake and all sources which are relevant making it an ideal instrument for risk assessment and risk management. HBM can identify new chemical exposures, trends and changes in expo...

Biomonitoring of human exposure to arylamines.

Extensive industrial use of arylamines started in the middle of the 19th century in the dye industry. Because of the high incidence of bladder cancer, arylamines belong to the first and most intensively studied occupational and environmental carcinogens. In workers, biomonitoring of exposure to arylamines including ortho-toluidine started in the first half of the 20th century. This review highl...

Human biomonitoring: research goals and needs.

Epidemiological studies have taken advantage of a number of strategies to monitor human populations for mortality, incidence, and exposure to hazardous environmental agents. These studies have been compromised by the lack of individual exposure assessment data that precisely quantified internal dose. As methods improve in analytical chemistry and molecular biology, direct biological monitoring ...